Press Release: PharmaLedger and GLEIF Support Innovation in Global Healthcare Services by Enabling Trusted Digital Identity
A collaboration between GLEIF and PharmaLedger has resulted in the Legal Entity Identifier (LEI) becoming a critical component of a new healthcare service blockchain platform.
PharmaLedger in collaboration with Global Legal Entity Identifier Foundation (GLEIF) have released a joint press release announcing our new partnership, supporting the design and adoption of blockchain-enabled healthcare solutions to deploy digital attestation of the Legal Entity Identifier (LEI) to thus provide robust, real-time identity verification and enable fast participant onboarding at scale. The press release covers:
- The collaboration between PharmaLedger and GLEIF
- Instant, global identity verification
- The benefits of digital trust in medical leaflets
- Instant onboarding and rapid partnering thanks to a digitally trusted base that permits sensitive data exchange, and more.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.